-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
January 01, 2021 - complaint of pain in other lower limb joints, neurological and cognitive impairments, knee surgery in the last … 6 months or infiltration in the knee(s) in the last 4 weeks, knee and/or hip prosthesis, contraindication … Exclusion:
Back surgery in the last 12 months, back pain from systemic
conditions, morbid obesity, … Exclusion:
Presence of systemic inflammatory arthritis, taking oral steroids in the last three months … , intra-articular corticosteroid injection for knee in the last six months, presence of neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
January 01, 2021 - complaint of pain in other lower limb joints, neurological and cognitive impairments, knee surgery in the last … 6 months or infiltration in the knee(s) in the last 4 weeks, knee and/or hip prosthesis, contraindication … Exclusion:
Back surgery in the last 12 months, back pain from systemic
conditions, morbid obesity, … Exclusion:
Presence of systemic inflammatory arthritis, taking oral steroids in the last three months … , intra-articular corticosteroid injection for knee in the last six months, presence of neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
January 01, 2022 - complaint of pain in other lower limb joints, neurological and cognitive impairments, knee surgery in the last … 6 months or infiltration in the knee(s) in the last 4 weeks, knee and/or hip prosthesis, contraindication … Exclusion:
Back surgery in the last 12 months, back pain from systemic
conditions, morbid obesity, … Exclusion:
Presence of systemic inflammatory arthritis, taking oral steroids in the last three months … , intra-articular corticosteroid injection for knee in the last six months, presence of neurological
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-appendix-d.xlsx
January 01, 2019 - prenatal visit, delivery, weeks between consent and last prenatal visit, estimated intake, percent kcals … pamphlets and booklets) and daily walks 33 Usual care; provided with pamphlets and booklets during last … B, 6 months
2941 (525) vs. 2941 (497)
9 months
3472 (498) vs. 3432 (538) Mean, g (SD)
A vs. … B, 6 months
87.6 (20.9) vs. 83.1 (16.8)
9 months
113.6 (20.6) vs. 103.4 (18.5), p<0.001 NR NR NR NR … B, 6 months
11.7 (3.0) vs. 13.1 (4.0)
9 months
15.9 (3.6) vs. 21.5 (5.7) NR Mean, g (SD)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-prepub-final-research-table-da.xlsx
January 01, 2019 - prenatal visit, delivery, weeks between consent and last prenatal visit, estimated intake, percent kcals … pamphlets and booklets) and daily walks 33 Usual care; provided with pamphlets and booklets during last … B, 6 months
2941 (525) vs. 2941 (497)
9 months
3472 (498) vs. 3432 (538) Mean, g (SD)
A vs. … B, 6 months
87.6 (20.9) vs. 83.1 (16.8)
9 months
113.6 (20.6) vs. 103.4 (18.5), p<0.001 NR NR NR NR … B, 6 months
11.7 (3.0) vs. 13.1 (4.0)
9 months
15.9 (3.6) vs. 21.5 (5.7) NR Mean, g (SD)
A vs.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - For the retrospective cohort, these were defined as the last physician seen
before death. … Improving processes of hospital care during
the last hours of life. … Denominator: Prospective: Subjects with at least 9
months out of the hospital during the 14 months … Denominator: Prospective: Subjects with at least 9
months out of the hospital during the 14 months … Denominator: Prospective: Subjects with at least 9
months out of the hospital during the 14 months
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-asthma.pdf
April 01, 2019 - The workgroup recommended using the first and last measurement within the parameter of
“interval of … interest” (generally 12 months). … Two
measurements within a 24-month period is also acceptable, if two
measurements within 12 months … • Use first and last
measurement if more than 2
measurements are
available in 12-month
period. … 12 months.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_consumer.pdf
November 01, 2016 - e
DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c- LowBackPain_consumer - Last … DRAFT: CONFIDENTIAL - For review only, not for dissemination - Task 3.7c - LowBackPain_consumer - Last … ��Tramadol helps to reduce pain in the
short term (up to 4 months). … ��Other opioids help a little to reduce
pain in the short term (up to 4
months). … ��Current research does not show that
opioids work or are safe in the long
term (longer than 4 months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-research-executive-summ.pdf
March 01, 2025 - * Represents the last search date of the ESR used to determine the start date of search for newer … primary evidence (generally the
last search date of the most recent ESR)
Abbreviations: CVD = cardiovascular … of more severe respiratory infections associated with
breastfeeding, particularly among infants ≤24 months … of moderate to severe GI infections and breastfeeding at
younger ages, particularly in infants ≤6 months … Dental
caries
Approximate 54% increased risk of dental caries associated with breastfeeding 12
months
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/carbohydrate-intake-protocol.pdf
April 08, 2024 - For infants 0 to 6 months of age the AI for
carbohydrate is 60 g/d, while for infants 6 to 12 months … Last reviewed
June 3, 2022. https://www.cdc.gov/obesity/basics/adult-defining.html#print
16. … Rockville, MD: Agency for Healthcare
Research and Quality; Content last reviewed December 2023. … Rockville, MD:
Agency for Healthcare Research and Quality; Content last reviewed December 2023. … Rockville, MD: Agency for
Healthcare Research and Quality; Content last reviewed March 2024.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - (range 4–13 months). … bi-
weekly searches will likely substantially change the conclusions or certainty of evidence of our last … Median followup time was 8 months (range 4–13 months). … For this estimate, strength of evidence is low for 7-10 months and insufficient for >10 months. … Hansen, 202135 10 months No difference in protection estimate
over time (3–6 months of followup
79·
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
January 01, 2019 - : 2.3 (2.0) vs. 2.8 (2.0)
12 months: 2.7 (2.3) vs. 2.7 (2.6)
24 months: 2.0 (2.1) vs. 2.8 (2.6)
Last … (2.7)
24 months: 2.1 (3.1) vs. 2.1 (2.6)
Last followup: 2.1 (2.9) vs. 2.1 (2.6) ODI
6 months: 18.2 … At last followup: 16.2 (17.8) vs. 14.2 (16.0) NR 4/51 vs. 3/51 NR Complications
Durotomy: 2/51 vs. 3/ … B
8.2 months (3.2) vs. 9.1 months (4.1) 72 63% NR NR NR 3 months
6 months A vs. … B
ITT analyses carrying forward last measures recorded before concurrent interventions occurred
VAS
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
January 01, 2024 - Follow-up Assessment Timepoints
Indicate all timepoints at which follow-up assessments were completed in months … after random assignment, and then every 6 months thereafter. … consent or adherence to protocol; inability to commence radiotherapy within 26 weeks of the date of last … malignancy other than nonmetastatic skin cancers or early stage small lymphocytic lymphoma within the last … after the end of therapy, then every 2-3 months for the first year and every 6 months for the next 4
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
September 02, 2016 - Matching Study Variables Between Published
Manuscript and CT.Gov
Eligible Study Record*: Author Last … Record Field** Published Manuscript(s) Agreement
[Primary completion date] Journal Pub date* NA
[Last … of regular
intercourse for women under 35, or 6 months for women 35 and older (alternate
definitions … of life if live birth
occurs
o Long-term
§ 12 months or more from completion of treatment (no live … of regular
intercourse for women under 35, or 6 months for women 35 and older (alternate
definitions
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/tympanostomy-tubes_research-protocol.pdf
November 16, 2015 - Myringotomy with tympanostomy tube placement with or without
adenoidectomy
o Short-term tubes (generally last … 10 to 18 months)
o Long-term tubes (e.g. … Last
accessed 3/27/2015.
5. Kleinman LC, Kosecoff J, Dubois RW, et al. … Last
accessed 7/25/2015.
21. Williams K, Thomson D, Seto I, et al. … Last accessed
7/25/2015.
24. Berkman ND, Lohr KN, Ansari M, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_consumer.pdf
August 01, 2017 - which a person has trouble falling asleep or
staying asleep, and the sleeping problem lasts at least 3 months … Insomnia disorder can last many years.
� You are age 18 or older. … for people with insomnia disorder, sleep problems
happen at least 3 nights each week for at least 3 months … But, these medicines are only
meant to be taken for short periods of time (4 weeks to 3 months). … ) and long term
(longer than 3 months).
»CBT-I does not appear to have side effects
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
September 30, 2015 - Pain > 3 months, currently prescribed opioids; excluded cancer and end-of-life treatment A. … B, at 3 months
Pain intensity (0 to 100 NRS converted to 0 to 10, mean change from baseline): -1.95 ( … in the pre period and up to 33 months in the post period
Exclusion: Cancer or sickle cell n=77,697
A … , dose NR, 23.0 months followup
C: Control (no opioid), new users (n=18,824), dose NA, 24.4 months followup … rounds over 2 years
A) Persistent opioid use: opioid use reported in 2 consecutive rounds before the last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - flap surgery (n=2)
• SRP, OHI, antibiotic prophylaxis, rubber cup prophylaxis (n=1)
• Time since last … Italy;
5/HD; NA; High;
CRP: NR
PCS;
3243;
1, 2, 3 years
(data shown for
3 years)
Treatment: Last … dental visit
≤6m
Control: Last
dental visit
>6m
Adjusted Hazard Ratio (95% CI); stratified … Most of the evidence base has been from studies conducted outside of the United States in the last
ten … CKD stage 5/HD;
NA;
Good (NOS)
3243
1, 2, 3 years
(data shown
for 3 years)
Treatment:
Last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
September 30, 2015 - Pain > 3 months, currently prescribed opioids; excluded cancer and end-of-life treatment A. … B, at 3 months
Pain intensity (0 to 100 NRS converted to 0 to 10, mean change from baseline): -1.95 ( … of followup Inclusion: 12 months of continuous opioid prescriptions of at least 50 morphine milligram … , dose NR, 23.0 months followup
C: Control (no opioid), new users (n=18,824), dose NA, 24.4 months followup … rounds over 2 years
A) Persistent opioid use: opioid use reported in 2 consecutive rounds before the last
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_overview.pdf
June 24, 2014 - compared to renal artery angioplasty with stent placement on long-term clinical
outcomes (at least 6 months … Considerations
§ An assessment of the last comparative effectiveness review conducted by AHRQ on this